Baxter Corporation; leaks of intravenous bags

Brand(s)

Last updated

2022-11-03

Summary

Product

0.9% SODIUM CHLORIDE INJECTION & LACTATED RINGER'S INJECTION

Issue

Health products - Product quality

What to do

Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.

Brand	Product Name	Market Authorization	Dosage Form	Strength	Lot number
BAXTER CORPORATION	0.9% SODIUM CHLORIDE INJECTION, USP	DIN 00060208	Solution	SODIUM CHLORIDE 900mg / 100mL	W1I14B0F, W1I15B0, W1I23B0, W1I24B0, W1I30B0, W1J07B0, W1J20B0, W1J22B0, W1J25B1, W1J26B0, W1J27B1, W1J29B0, W1K02B0, W1K03B0, W1K19B0, W1K25B0, W1K25B0F, W1L02B0, W1L03B0, W1L09B0, W1L10B0, W1L10B0B, W1L11B0, W1L16B0, W1L17B0, W2A13B0, W2A14B0, W2A19B1, W2A20B0, W2A21B0, W2A22B0, W2A26B0, W2A29B0, W1H13B0, W1H19B0, W1H20B0, W1H26B0, W1H27B0, W1I01B0, W1I03B0, W1I09B0, W1I10B0, W1I14B0
BAXTER CORPORATION	LACTATED RINGER'S INJECTION, USP	DIN 00061085	Solution	CALCIUM CHLORIDE 20mg / 100mL; POTASSIUM CHLORIDE 30mg / 100mL; SODIUM CHLORIDE 600mg / 100 mL; SODIUM LACTATE 310mg / 100mL	W1H04B0, W1I17B0, W1J28B0, W1K26B0, W1L22B0, W2A27B0, W2A27B0S

Intravenous bag may be leaking in affected lots.

Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.

Background

Depth of recall: End Users

Details

Original published date: 2022-11-03

Alert / recall type

Health product recall

Receive notifications for new and updated recalls and alerts by category.